HIV/AIDS treatment and HIV vaccines for Africa
- 1 June 2002
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 359 (9325) , 2261-2267
- https://doi.org/10.1016/s0140-6736(02)09297-8
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Disappointing Data Scuttle Plans for Large-Scale AIDS Vaccine TrialScience, 2002
- Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityNature, 2002
- Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adultsAIDS, 2001
- Impact of Human Immunodeficiency Virus Type 1 (HIV‐1) Subtype on Women Receiving Single‐Dose Nevirapine Prophylaxis to Prevent HIV‐1 Vertical Transmission (HIV Network for Prevention Trials 012 Study)The Journal of Infectious Diseases, 2001
- Future access to HIV vaccinesAIDS, 2001
- Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA VaccineScience, 2001
- Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adultsAIDS, 2001
- Sequence and Drug Susceptibility of Subtype C Protease from Human Immunodeficiency Virus Type 1 Seroconverters in ZimbabweAIDS Research and Human Retroviruses, 1999
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Drug Susceptibility of Subtypes A, B, C, D, and E Human Immunodeficiency Virus Type 1 Primary IsolatesAIDS Research and Human Retroviruses, 1998